Home
Stempoint Capital reported a 9.5% stake in Xilio Therapeutics XLO · 628,866 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.5%
- Last report
- 8.4% · filed 26/02/17
- Shares held
- 628,866 sh
- Class
- Common stock, par value $0.0001 per share
- Holder
- Stempoint Capital
- Event date
- 26/06/30
- Filed
- 26/08/14
9.5% stake · +1.1pp from the last report
- Stake
- 9.5%
- Last report
- 8.4%
- Since last report
- +1.1pp
Xilio Therapeutics trades, last 26 weeks
What else happened in Xilio Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Stempoint Capital's other 5% stake reports
- Stempoint Capital
5% stakeSurrozen
5% stakeSurrozen
SRZN
5% stake
602,798 sh
5% stake
Filed 08/14
- Stempoint Capital
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
0% stake
0 sh
0% stake
Filed 08/14
- Stempoint Capital
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
9.9% stake
845,740 sh
9.9% stake
Filed 08/14
- Stempoint Capital
5% stakeSurrozen
5% stakeSurrozen
SRZN
4.5% stake
525,639 sh
4.5% stake
Filed 05/15
- Stempoint Capital
5% stakeFaeth Therapeutics
5% stakeFaeth Therapeutics
FTH
9.9% stake
132,873 sh
9.9% stake
Filed 05/15
